4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Sionna Therapeutics, Inc. (SION) operates in the Biotechnology industry and is headquartered in Waltham, United States with about 59 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, SION reported $0M in revenue and ($75M) in net income.
Sionna Therapeutics, Inc., a clinical-stage biopharmaceutical company, researches and develops medicines for the treatment of cystic fibrosis (CF).
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M |
| Operating Income (EBIT) | ($89M) | ($71M) | ($50M) | ($41M) |
| Net Income | ($75M) | ($62M) | ($47M) | ($40M) |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | — |
| Operating Income (EBIT) | ($30M) | ($24M) | ($24M) | ($22M) | ($20M) | — |
| Net Income | ($27M) | ($20M) | ($20M) | ($18M) | ($16M) | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Total Assets | $326M | $186M | $52M | $87M |
| Total Liabilities | $19M | $350M | $167M | $157M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive SION viewer.
About TickerBase · Data methodology & sources